In Australia, cryptocurrencies are getting more scrutiny from regulators.
Reuters reports that the country has moved oversight of digital currency providers to its financial intelligence agency AUSTRAC.
The shift is immediate, reported the newswire, and represents the first steps to strengthen efforts under the country’s Anti-Money Laundering and Counter Terrorism Financing Act.
All exchange providers that traffic in cryptocurrencies within Australia’s borders must register with the agency. Reuters reported the move is aimed at reducing the risk of money laundering and terrorism financing.
“AUSTRAC now has increased opportunities to facilitate the sharing of financial intelligence and information relating to the use of digital currencies, such as bitcoin and other cryptocurrencies, with its industry and government partners,” Chief Executive Nicole Rose said. “The information that these businesses will collect and report to AUSTRAC will have immediate benefit in the fight against serious crime and terrorism financing.”
The Anti-Money Laundering and Counter Terrorism Financing Act mandates that regulated entities — spanning banks and money transfer firms — collect data that ascertains the identities of customers involved in transactions. The Act also stipulates that firms must oversee those transactions, with an eye on suspicious activity that handles sums over AUD$10,000 (US$7,759).
As reported, the shift comes more than two years after the Financial Action Task Force reported that there were deficiencies in the country’s anti-money laundering efforts.
“The next and more challenging phase of legislative reforms in Australia,” said Reuters, “will be to extend the rules to lawyers, accountants, real estate agents and dealers in high-value goods.”
Full Content: PYMNTS
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas